Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan
Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
In Vivo. 2022 Mar-Apr;36(2):1035-1040. doi: 10.21873/invivo.12799.
Head and neck photoimmunotherapy specifically destroys tumor cells by irradiating them with 690 nm red light after administering cetuximab sarotalocan sodium. The key point in the technique of photoimmunotherapy is to set the irradiation area precisely with a margin added to the target lesion while securing a safety zone with large vessels such as the internal carotid artery.
At our Institution, we performed photoimmunotherapy in combination with use of a navigation system on a male patient in his 70s with maxillary gingival carcinoma who had a recurrent lesion deep in the lateral pterygoid muscle. Three months after photoimmunotherapy, the superficial lesion had disappeared, the area of contrast within the lateral pterygoid muscle had improved, and the patient was deemed to have a complete response.
The Navigation System was successfully used in combination with photoimmunotherapy. Additionally, this allowed the location of the internal carotid artery to be confirmed in real time.
头颈部光免疫疗法通过在给予西妥昔单抗沙罗妥坎钠后用 690nm 红光照射来特异性地破坏肿瘤细胞。光免疫疗法技术的关键在于在目标病变上添加边缘以精确设置照射区域,同时在颈内动脉等大血管周围确保安全区域。
在我们的机构,我们对一位 70 多岁的上颌牙龈癌男性患者进行了光免疫疗法联合导航系统治疗,该患者的外侧翼状肌深部有复发病灶。光免疫疗法 3 个月后,表面病变消失,外侧翼状肌内的对比区域得到改善,患者被认为完全缓解。
导航系统成功地与光免疫疗法结合使用。此外,这使得能够实时确认颈内动脉的位置。